148 related articles for article (PubMed ID: 25758549)
21. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
[TBL] [Abstract][Full Text] [Related]
22. Motor sequencing abnormalities are the trait marking neurological soft signs of schizophrenia.
Ojagbemi A; Esan O; Emsley R; Gureje O
Neurosci Lett; 2015 Jul; 600():226-31. PubMed ID: 26101827
[TBL] [Abstract][Full Text] [Related]
23. Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months.
Luckhoff H; Phahladira L; Scheffler F; Asmal L; du Plessis S; Chiliza B; Kilian S; Emsley R
Schizophr Res; 2019 Apr; 206():171-176. PubMed ID: 30503765
[TBL] [Abstract][Full Text] [Related]
24. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia.
Prikryl R; Ceskova E; Kasparek T; Kucerova H
J Psychiatr Res; 2006 Mar; 40(2):141-6. PubMed ID: 15907940
[TBL] [Abstract][Full Text] [Related]
25. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Emsley R; Asmal L; Chiliza B; du Plessis S; Carr J; Kidd M; Malhotra AK; Vink M; Kahn RS
Psychiatry Res; 2015 Aug; 233(2):186-93. PubMed ID: 26184461
[TBL] [Abstract][Full Text] [Related]
26. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
[TBL] [Abstract][Full Text] [Related]
27. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project.
Bola JR; Mosher LR
J Nerv Ment Dis; 2003 Apr; 191(4):219-29. PubMed ID: 12695732
[TBL] [Abstract][Full Text] [Related]
28. Predictors of 10-year outcome of first-episode psychosis.
White C; Stirling J; Hopkins R; Morris J; Montague L; Tantam D; Lewis S
Psychol Med; 2009 Sep; 39(9):1447-56. PubMed ID: 19187566
[TBL] [Abstract][Full Text] [Related]
29. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
Buckley PF
CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
[No Abstract] [Full Text] [Related]
31. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
32. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
[TBL] [Abstract][Full Text] [Related]
33. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.
Chang WC; Hui CL; Tang JY; Wong GH; Chan SK; Lee EH; Chen EY
Psychol Med; 2013 Sep; 43(9):1883-93. PubMed ID: 23217676
[TBL] [Abstract][Full Text] [Related]
34. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis.
Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A
Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977
[TBL] [Abstract][Full Text] [Related]
35. Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.
Ovenden ES; Drögemöller BI; van der Merwe L; Chiliza B; Asmal L; Emsley RA; Warnich L
Pharmacogenomics; 2017 Jan; 18(2):105-120. PubMed ID: 27992301
[TBL] [Abstract][Full Text] [Related]
36. Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.
Emsley R; Oosthuizen PP; Koen L; Niehaus DJ; Martinez G
J Clin Psychiatry; 2012 Apr; 73(4):e541-7. PubMed ID: 22579160
[TBL] [Abstract][Full Text] [Related]
37. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
38. Remission in first-episode psychosis: predictor variables and symptom improvement patterns.
Emsley R; Oosthuizen PP; Kidd M; Koen L; Niehaus DJ; Turner HJ
J Clin Psychiatry; 2006 Nov; 67(11):1707-12. PubMed ID: 17196049
[TBL] [Abstract][Full Text] [Related]
39. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
